Minireview: Nesfatin-1 - An emerging new player in the brain-gut, endocrine, and metabolic axis

Endocrinology

Volumn 152, Issue 11, 2011, Pages 4033-4038

  Stengel, Andreas ^a,b   Taché, Yvette ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MESSENGER RNA; NESFATIN 1; PROTEIN; UNCLASSIFIED DRUG;

ADAPTATION; ADRENERGIC SYSTEM; BRAIN; EMOTION; ENDOCRINE SYSTEM; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; INSULIN LIKE ACTIVITY; INTESTINE; METABOLISM; MOLECULAR MECHANICS; NEUROENDOCRINE SYSTEM; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SHORT SURVEY; STRESS;

ANIMALS; BRAIN; ENDOCRINE SYSTEM; ENERGY METABOLISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NERVE TISSUE PROTEINS; NEURONS; PITUITARY-ADRENAL SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 80054933215     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1500     Document Type: Short Survey

References (58)

1. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M 2006 Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443:709-712 (Pubitemid 44564715)
2. Gonzalez R, Kerbel B, Chun A, Unniappan S 2010 Molecular, cellular and physiological evidences for the anorexigenic actions of nesfatin-1 in goldfish. PLoS One 5:e15201
3. Stengel A, Goebel M, Taché Y 2011 Nesfatin-1: a novel inhibitory regulator of food intake and body weight. Obes Rev 12:267-271
4. Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, Dun NJ 2007 Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 148:5088-5094 (Pubitemid 47481535)
5. Foo KS, Brismar H, Broberger C 2008 Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience 156:563-579
6. Fort P, Salvert D, Hanriot L, Jego S, Shimizu H, Hashimoto K, Mori M, Luppi PH 2008 The satiety molecule nesfatin-1 is co-expressed with melanin concentrating hormone in tuberal hypothalamic neurons of the rat. Neuroscience 155:174-181
7. Kohno D, Nakata M, Maejima Y, Shimizu H, Sedbazar U, Yoshida N, Dezaki K, Onaka T, Mori M, Yada T 2008 Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 149:1295-1301 (Pubitemid 351397928)
8. Inhoff T, Stengel A, Peter L, Goebel M, Taché Y, Bannert N, Wiedenmann B, Klapp BF, Mönnikes H, Kobelt P 2010 Novel insight in distribution of nesfatin-1 and phospho-mTOR in the arcuate nucleus of the hypothalamus of rats. Peptides 31:257-262
9. Goebel M, Stengel A, Wang L, Lambrecht NW, Taché Y 2009 Nesfatin-1 immunoreactivity in rat brain and spinal cord autonomic nuclei. Neurosci Lett 452:241-246
10. Goebel-Stengel M, Wang L, Stengel A, Taché Y 2011 Localization of nesfatin-1 neurons in the mouse brain and functional implication. Brain Res 1396:20-34
11. Maejima Y, Sedbazar U, Suyama S, Kohno D, Onaka T, Takano E, Yoshida N, Koike M, Uchiyama Y, Fujiwara K, Yashiro T, Horvath TL, Dietrich MO, Tanaka S, Dezaki K, Oh-I S, Hashimoto K, Shimizu H, Nakata M, Mori M, Yada T 2009 Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab 10:355-365
12. Okere B, Xu L, Roubos EW, Sonetti D, Kozicz T 2010 Restraint stress alters the secretory activity of neurons co-expressing urocortin-1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 in the mouse Edinger-Westphal nucleus. Brain Res 1317:92-99
13. Stengel A, Goebel M, Yakubov I, Wang L, Witcher D, Coskun T, Taché Y, Sachs G, Lambrecht NW 2009 Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 150:232-238
14. Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, Kern W, Hillhouse EW, Lehnert H, Tan BK, Randeva HS 2010 Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 151:3169-3180
15. Foo KS, Brauner H, Ostenson CG, Broberger C 2010 Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J Endocrinol 204:255-263
16. Gonzalez R, Tiwari A, Unniappan S 2009 Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem Biophys Res Commun 381:643-648
17. Tsuchiya T, Shimizu H, Yamada M, Osaki A, Oh IS, Ariyama Y, Takahashi H, Okada S, Hashimoto K, Satoh T, Kojima M, Mori M 2010 Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) 73:484-490
18. Kastin AJ, Pan W 2003 Feeding peptides interact in several ways with the blood-brain barrier. Curr Pharm Des 9:789-794 (Pubitemid 36367600)
19. Price TO, Samson WK, Niehoff ML, Banks WA 2007 Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 28:2372-2381 (Pubitemid 350123562)
20. Pan W, Hsuchou H, Kastin AJ 2007 Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides 28:2223-2228 (Pubitemid 47600423)
21. Tan BK, Hallschmid M, Kern W, Lehnert H, Randeva HS 2011 Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment. J Clin Endocrinol Metab 96:E669-E673
22. García-Galiano D, Navarro VM, Roa J, Ruiz-Pino F, Sánchez-Garrido MA, Pineda R, Castellano JM, Romero M, Aguilar E, Gaytán F, Diéguez C, Pinilla L, Tena-Sempere M 2010 The anorexigenic neuropeptide, nesfatin-1, is indispensable for normal puberty onset in the female rat. J Neurosci 30:7783-7792
23. Goebel M, Stengel A, Wang L, Taché Y 2011 Central nesfatin-1 reduces the nocturnal food intake in mice by reducing meal size and increasing inter-meal intervals. Peptides 32:36-43
24. Stengel A, Goebel M, Wang L, Rivier J, Kobelt P, Mö nnikes H, Lambrecht NW, Taché Y 2009 Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin- releasing factor2 receptor. Endocrinology 150:4911-4919
25. Yosten GL, Samson WK 2010 The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am J Physiol Regul Integr Comp Physiol 298:R1642-R1647
26. Atsuchi K, Asakawa A, Ushikai M, Ataka K, Tsai M, Koyama K, Sato Y, Kato I, Fujimiya M, Inui A 2010 Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. Neuroreport 21:1008-1011
27. Taché Y, Garrick T, Raybould H 1990 Central nervous system action of peptides to influence gastrointestinal motor function. Gastroenterology 98:517-528 (Pubitemid 20037941)
28. Nonogaki K, Ohba Y, Sumii M, Oka Y 2008 Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice. Biochem Biophys Res Commun 372:186-190
29. Zorrilla EP, Taché Y, Koob GF 2003 Nibbling at CRF receptor control of feeding and gastrocolonic motility. Trends Pharmacol Sci 24:421-427 (Pubitemid 36952559)
30. Tabarin A, Diz-Chaves Y, Consoli D, Monsaingeon M, Bale TL, Culler MD, Datta R, Drago F, Vale WW, Koob GF, Zorrilla EP, Contarino A 2007 Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis. Eur J Neurosci 26:2303-2314 (Pubitemid 47620499)
31. Yosten GL, Samson WK 2009 Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. Am J Physiol Regul Integr Comp Physiol 297:R330-R336
32. Price CJ, Samson WK, Ferguson AV 2008 Nesfatin-1 inhibits NPY neurons in the arcuate nucleus. Brain Res 1230:99-106
33. Xu B, Kalra PS, Farmerie WG, Kalra SP 1999 Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction. Endocrinology 140:2868-2875 (Pubitemid 32245168)
34. Taheri S, Sunter D, Dakin C, Moyes S, Seal L, Gardiner J, Rossi M, Ghatei M, Bloom S 2000 Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neurosci Lett 279:109-112 (Pubitemid 30055293)
35. Lu XY, Shieh KR, Kabbaj M, Barsh GS, Akil H, Watson SJ 2002 Diurnal rhythm of agouti-related protein and its relation to corticosterone and food intake. Endocrinology 143:3905-3915 (Pubitemid 35244370)
36. Noetzel S, Stengel A, Inhoff T, Goebel M, Wisser AS, Bannert N, Wiedenmann B, Klapp BF, Taché Y, Mönnikes H, Kobelt P 2009 CCK-8S activates c-Fos in a dose-dependent manner in nesfatin-1 immunoreactive neurons in the paraventricular nucleus of the hypothalamus and in the nucleus of the solitary tract of the brainstem. Regul Pept 157:84-91
37. Shimizu H, Oh-I S, Hashimoto K, Nakata M, Yamamoto S, Yoshida N, Eguchi H, Kato I, Inoue K, Satoh T, Okada S, Yamada M, Yada T, Mori M 2009 Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 150:662-671
38. 2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-type channels. Biochem Biophys Res Commun 390:958-962
39. Shimizu H, Ohsaki A, Oh-I S, Okada S, Mori M 2009 A new anorexigenic protein, nesfatin-1. Peptides 30:995-998
40. Li QC, Wang HY, Chen X, Guan HZ, Jiang ZY 2010 Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 159:72-77
41. Ogiso K, Asakawa A, Amitani H, Nakahara T, Ushikai M, Haruta I, Koyama K, Amitani M, Harada T, Yasuhara D, Inui A 2011 Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa. Peptides 32:150-153
42. Zegers D, Beckers S, Mertens IL, Van Gaal LF, Van Hul W 2011 Association between polymorphisms of the Nesfatin gene, NUCB2, and obesity in men. Mol Genet Metab 103:282-286
43. Bale TL, Vale WW 2004 CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44:525-557 (Pubitemid 38263852)
44. Stengel A, Taché Y 2010 Corticotropin-releasing factor signaling and visceral response to stress. Exp Biol Med (Maywood) 235:1168-1178
45. Shimizu T, Lu L, Yokotani K 2010 Possible inhibitory roles of endogenous 2-arachidonoylglycerol during corticotropin-releasing factor-induced activation of central sympatho-adrenomedullary outflow in anesthetized rats. Eur J Pharmacol 641:54-60
46. Yoshida N, Maejima Y, Sedbazar U, Ando A, Kurita H, Damdindorj B, Takano E, Gantulga D, Iwasaki Y, Kurashina T, Onaka T, Dezaki K, Nakata M, Mori M, Yada T 2010 Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary- adrenal axis. Aging (Albany NY) 2:775-784
47. Merali Z, Cayer C, Kent P, Anisman H 2008 Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology (Berl) 201:115-123
48. Tanida M, Mori M 2011 Nesfatin-1 stimulates renal sympathetic nerve activity in rats. Neuroreport 22:309-312
49. Stengel A, Taché Y 2009 Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight. Annu Rev Physiol 71:219-239
50. Stengel A, Goebel M, Wang L, Taché Y 2010 Abdominal surgery activates nesfatin-1 immunoreactive brain nuclei in rats. Peptides 31:263-270
51. Bonnet MS, Pecchi E, Trouslard J, Jean A, Dallaporta M, Troadec JD 2009 Central nesfatin-1 expressing neurons are sensitive to peripheral inflammatory stimulus. J Neuroinflammation 6:27
52. Goebel M, Stengel A, Wang L, Taché Y 2009 Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res 1300:114-124
53. Könczöl K, Bodnár I, Zelena D, Pintér O, Papp RS, Palkovits M, Nagy GM, Tóth ZE 2010 Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic-pituitary-adrenal axis in rats. Neurochem Int 57:189-197
54. Xu L, Bloem B, Gaszner B, Roubos EW, Kozicz T 2010 Stress-related changes in the activity of cocaine- and amphetamine-regulated transcript and nesfatin neurons in the midbrain non-preganglionic Edinger-Westphal nucleus in the rat. Neuroscience 170:478-488
55. Gonzalez R, Reingold BK, Gao X, Gaidhu MP, Tsushima RG, Unniappan S 2011 Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet β- and MIN6 cells. J Endocrinol 208:R9-R16
56. 2+ influx through L-type channels in mouse islet β-cells. Endocr J 58:305-313
57. Su Y, Zhang J, Tang Y, Bi F, Liu JN 2010 The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun 391:1039-1042
58. Aydin S 2010 The presence of the peptides apelin, ghrelin and nesfatin-1 in the human breast milk, and the lowering of their levels in patients with gestational diabetes mellitus. Peptides 31:2236-2240